These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21813044)

  • 1. Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis.
    Verma A; Prasad KN; Nyati KK; Singh SK; Singh AK; Paliwal VK; Gupta RK
    Parasitology; 2011 Sep; 138(11):1423-8. PubMed ID: 21813044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI.
    Gupta RK; Awasthi R; Rathore RK; Verma A; Sahoo P; Paliwal VK; Prasad KN; Pandey CM; Narayana PA
    Neurology; 2012 Feb; 78(9):618-25. PubMed ID: 22302547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India.
    Prasad KN; Verma A; Srivastava S; Gupta RK; Pandey CM; Paliwal VK
    Trans R Soc Trop Med Hyg; 2011 Sep; 105(9):531-6. PubMed ID: 21764415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
    Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
    Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of ICAM-1 among symptomatic neurocysticercosis.
    Prasad A; Prasad KN; Gupta RK; Pradhan S
    J Neuroimmunol; 2009 Jan; 206(1-2):118-20. PubMed ID: 18947884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.
    Sapienza P; Borrelli V; di Marzo L; Cavallaro A
    Eur J Vasc Endovasc Surg; 2009 May; 37(5):525-30. PubMed ID: 19297218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
    Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What triggers seizures in neurocysticercosis? A MRI-based study in pig farming community from a district of North India.
    Prasad A; Gupta RK; Pradhan S; Tripathi M; Pandey CM; Prasad KN
    Parasitol Int; 2008 Jun; 57(2):166-71. PubMed ID: 18234551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus.
    Shiau MY; Tsai ST; Tsai KJ; Haung ML; Hsu YT; Chang YH
    Mt Sinai J Med; 2006 Nov; 73(7):1024-8. PubMed ID: 17195891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus.
    Derosa G; Avanzini MA; Geroldi D; Fogari R; Lorini R; De Silvestri A; Tinelli C; Rondini G; d'Annunzio G
    Diabetes Res Clin Pract; 2005 Nov; 70(2):119-25. PubMed ID: 16188574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases in blood from patients with LAM.
    Odajima N; Betsuyaku T; Nasuhara Y; Inoue H; Seyama K; Nishimura M
    Respir Med; 2009 Jan; 103(1):124-9. PubMed ID: 18760908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
    Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
    Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 polymorphism and its association with symptomatic neurocysticercosis.
    Verma A; Prasad KN; Gupta RK; Singh AK; Nyati KK; Rizwan A; Pandey CM; Paliwal VK
    J Infect Dis; 2010 Oct; 202(8):1219-25. PubMed ID: 20807077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.